Results 21 to 30 of about 1,543,151 (246)
First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI) [PDF]
The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic ...
Hammerstingl, Renate Maria +6 more
core +1 more source
Background The tumour suppressor phosphatase and tensin homolog (PTEN) is an important negative regulator of cell-survival signaling. To evaluate the correlation between PTEN expression and clinicopathological characteristics of colorectal cancer ...
Funahashi Hitoshi +9 more
doaj +1 more source
Colorectal cancer with synchronous liver metastases: terminology, diagnosis and management
Colorectal cancer with synchronous liver metastases: terminology, diagnosis and ...
O. Yu. Usenko, A. A. Skums
doaj +1 more source
Liver resection for colorectal metastases [PDF]
Colorectal cancer is the second commonest malignancy in the UK. Metastases to the liver occur in greater than 50% of patients and remain the biggest determinant of outcome in these patients. Liver resection is a safe procedure that achieves good long-term survival, but surgery has traditionally been limited to select groups of patients.
S R, Bramhall +8 more
openaire +2 more sources
Can localised 19F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response? [PDF]
Background 5-Fluorouracil remains widely used in colorectal cancer treatment more than 40 years after its development. 19F magnetic resonance spectroscopy can be used in vivo to measure 5FU’s half-life and metabolism to cytotoxic fluoronucleotides ...
Griffiths, John R. +17 more
core +1 more source
International audienceOutcome of patients who develop resectable metachronous colorectal liver metastases (CLM) after adjuvant oxaliplatin‐based chemotherapy for Stage III colorectal cancer (CRC) is not well defined and the value of preoperative ...
Pessaux, Patrick +13 more
core +1 more source
Surgical treatment of colorectal cancer metastases [PDF]
Background/Aim: Colorectal metastatic liver tumours are the most common secondary liver tumours. During the life of patients with colorectal tumorous, this liver metastases will develop either synchronously or metachronously in half of the patients ...
Škrbić Velimir +3 more
doaj
Background: To determine the long-term outcomes of radiofrequency ablation with respect to overall survival, disease-free survival, and complications in patients with colorectal cancer liver metastases.
Okan Akhan +11 more
core +1 more source
Prognostic Factors after Liver Resection for Colorectal Liver Metastasis
Introduction: Surgery is the only potentially curative treatment for patients with colorectal liver metastases, resulting in 5-year survival rates of 36–58%.
Margarida Matias +6 more
doaj +1 more source
The liver is the main target organ for hematogenous metastases of colorectal cancer, and colorectal liver metastasis is one of the most difficult and challenging situations in the treatment of colorectal cancer.
Li Ren +12 more
doaj +1 more source

